$PMDI
PSYCHEMEDICS CORP Stock $pmdi

$pmdi Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000117184320007845 Filed on November 10, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$5.335M	$5.174M	$9.852M
YoY Change	-38.78%	-47.48%	-10.57%
Cost Of Revenue	$4.060M	$4.041M	$5.470M
YoY Change	-22.37%	-26.12%	-3.32%
Gross Profit	$1.277M	$1.133M	$4.382M
YoY Change	-63.36%	-74.14%	-18.22%
Gross Profit Margin	23.94%	21.9%	44.48%
Selling, General & Admin	$2.090M	$2.237M	$2.655M
YoY Change	-44.12%	-15.74%	-7.36%
% of Gross Profit	163.66%	197.44%	60.59%
Research & Development	$300.0K	$305.0K	$393.0K
YoY Change	-14.29%	-22.39%	5.65%
% of Gross Profit	23.49%	26.92%	8.97%
Depreciation & Amortization	$690.0K	$710.0K	$720.0K
YoY Change	0.0%	-1.39%	-6.49%
% of Gross Profit	54.03%	62.67%	16.43%
Operating Expenses	$2.380M	$2.542M	$3.048M
YoY Change	-41.81%	-16.6%	-5.87%
Operating Profit	-$1.109M	-$1.409M	$1.334M
YoY Change	83.0%	-205.62%	-37.08%
Interest Expense	-$10.00K	-$20.00K	$10.00K
YoY Change		-300.0%	-62.96%
% of Operating Profit			0.75%
Other Income/Expense, Net		-$17.00K	$6.000K
YoY Change		-383.33%	-166.67%
Pretax Income	-$1.120M	-$1.426M	$1.340M
YoY Change	86.67%	-206.42%	-36.52%
Income Tax	-$580.0K	-$319.0K	$663.0K
% Of Pretax Income			49.48%
Net Earnings	-$543.0K	-$1.107M	$677.0K
YoY Change	2.45%	-263.52%	-46.9%
Net Earnings / Revenue	-10.18%	-21.4%	6.87%
Basic Earnings Per Share	-$0.10	-$0.20	$0.12
Diluted Earnings Per Share	-$0.10	-$0.20	$0.12
COMMON SHARES
Basic Shares Outstanding	5.526M	5.526M	5.517M
Diluted Shares Outstanding		5.526M	5.517M

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.830M	$1.810M	$6.490M
YoY Change	-61.13%	-72.11%	7.81%
Cash & Equivalents	$2.833M	$1.809M	$6.492M
Short-Term Investments			$0.00
Other Short-Term Assets	$910.0K	$1.300M	$1.820M
YoY Change	-49.16%	-28.57%	33.82%
Inventory
Prepaid Expenses
Receivables	$3.356M	$3.890M	$5.171M
Other Receivables	$2.490M	$1.830M	$0.00
Total Short-Term Assets	$9.598M	$8.831M	$13.49M
YoY Change	-25.31%	-34.52%	-12.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.231M	$9.746M	$9.139M
YoY Change	-15.02%	6.64%	-14.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$888.0K	$885.0K	$944.0K
YoY Change	-5.83%	-6.25%	4.89%
Total Long-Term Assets	$14.41M	$15.15M	$13.30M
YoY Change	-1.87%	13.93%	15.19%
TOTAL ASSETS
Total Short-Term Assets	$9.598M	$8.831M	$13.49M
Total Long-Term Assets	$14.41M	$15.15M	$13.30M
Total Assets	$24.00M	$23.98M	$26.78M
YoY Change	-12.81%	-10.47%	-0.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$577.0K	$416.0K	$372.0K
YoY Change	-6.48%	11.83%	-54.24%
Accrued Expenses	$1.801M	$1.357M	$2.727M
YoY Change	-49.65%	-50.24%	-30.22%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$688.0K	$685.0K	$416.0K
YoY Change	1.47%	64.66%	-55.79%
Total Short-Term Liabilities	$3.941M	$3.342M	$4.686M
YoY Change	-32.46%	-28.68%	-17.24%
LONG-TERM LIABILITIES
Long-Term Debt	$3.444M	$3.617M	$900.0K
YoY Change	76.52%	301.89%	-47.64%
Other Long-Term Liabilities	$3.900M	$4.080M	$2.360M
YoY Change	63.87%	72.88%
Total Long-Term Liabilities	$3.444M	$3.617M	$900.0K
YoY Change	76.52%	301.89%	-47.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.941M	$3.342M	$4.686M
Total Long-Term Liabilities	$3.444M	$3.617M	$900.0K
Total Liabilities	$11.49M	$11.04M	$8.764M
YoY Change	7.28%	25.95%	3.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.606M	-$8.063M	-$2.232M
YoY Change	129.25%	261.25%	83.55%
Common Stock	$32.83M	$32.72M	$32.03M
YoY Change	1.72%	2.16%	2.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.08M	$10.08M	$10.08M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	$668.0K	$668.0K	$668.0K
Shareholders Equity	$12.51M	$12.94M	$18.02M
YoY Change
Total Liabilities & Shareholders Equity	$24.00M	$23.98M	$26.78M
YoY Change	-12.81%	-10.47%	-0.75%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	-$543.0K	-$1.107M	$677.0K
YoY Change	2.45%	-263.52%	-46.9%
Depreciation, Depletion And Amortization	$690.0K	$710.0K	$720.0K
YoY Change	0.0%	-1.39%	-6.49%
Cash From Operating Activities	$1.140M	-$1.490M	$1.670M
YoY Change	20.0%	-189.22%	307.32%
INVESTING ACTIVITIES
Capital Expenditures	$70.00K	-$250.0K	-$760.0K
YoY Change	-112.5%	-67.11%	24.59%
Acquisitions
YoY Change
Other Investing Activities	-$20.00K	$20.00K	-$60.00K
YoY Change	100.0%	-133.33%
Cash From Investing Activities	$50.00K	-$230.0K	-$830.0K
YoY Change	-108.93%	-72.29%	38.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-170.0K	-170.0K	-1.090M
YoY Change	-153.13%	-84.4%	-12.1%
NET CHANGE
Cash From Operating Activities	1.140M	-1.490M	1.670M
Cash From Investing Activities	50.00K	-230.0K	-830.0K
Cash From Financing Activities	-170.0K	-170.0K	-1.090M
Net Change In Cash	1.020M	-1.890M	-250.0K
YoY Change	43.66%	656.0%	-82.52%
FREE CASH FLOW
Cash From Operating Activities	$1.140M	-$1.490M	$1.670M
Capital Expenditures	$70.00K	-$250.0K	-$760.0K
Free Cash Flow	$1.070M	-$1.240M	$2.430M
YoY Change	-29.14%	-151.03%	138.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Security12b Title Security12bTitle	Common stock. $0.005 par value
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5526493
CY2020Q3	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	100000
	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	1300000
	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	-2219000
	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	-220000
	pmd	Increase Decrease In Operating Lease Rou Assets And Liabilities IncreaseDecreaseInOperatingLeaseROUAssetsAndLiabilities	-721000
	pmd	Increase Decrease In Operating Lease Rou Assets And Liabilities IncreaseDecreaseInOperatingLeaseROUAssetsAndLiabilities
CY2020Q3	pmd	Lessee Operating Lease Liability Payments Due Year Six LesseeOperatingLeaseLiabilityPaymentsDueYearSix	458000
	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	507000
	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	312000
	pmd	Rightofuse Asset Amortization RightofuseAssetAmortization	713000
	pmd	Rightofuse Asset Amortization RightofuseAssetAmortization
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	416000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	617000
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3890000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3780000
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1357000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3577000
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16257000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16197000
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1624000
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32690000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32249000
CY2020Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8000
CY2019Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	33000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	163000
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	190000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	449000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	509000
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	40000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	45000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	594000
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	594000
CY2020Q3	us-gaap	Assets Assets	23980000
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	160000
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	126000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	158000
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	161000
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	190000
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	126000
CY2019Q4	us-gaap	Assets Assets	27531000
CY2020Q3	us-gaap	Assets Current AssetsCurrent	8831000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	12851000
CY2020Q3	us-gaap	Cash Cash	1809000
CY2019Q4	us-gaap	Cash Cash	7283000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7283000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4069000
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1809000
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6492000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5474000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2423000
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2019Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2019Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2020Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.54
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6195000
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6185000
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6195000
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6185000
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	31000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	31000
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1107000
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	347000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3326000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1775000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4041000
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5470000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12416000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16004000
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	10000
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	550000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1995000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2219000
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">13.</div>       Accounting Pronouncements Issued But <div style="display: inline; font-style: italic; font: inherit;">Not</div> Yet Effective</div></div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; margin: 0pt 0; text-indent: 0.25in">In <div style="display: inline; font-style: italic; font: inherit;"> December 2019, </div>the Financial Accounting Standards Board (“FASB”) issued ASU <div style="display: inline; font-style: italic; font: inherit;">2019</div>-<div style="display: inline; font-style: italic; font: inherit;">12,</div> “Income Taxes (Topic <div style="display: inline; font-style: italic; font: inherit;">740</div>): Simplifying the Accounting for Income Taxes”, which is intended to simplify the accounting for income taxes. This ASU removes certain exceptions to the general principles in Topic <div style="display: inline; font-style: italic; font: inherit;">740</div> and clarifies and amends existing guidance to improve consistent application. The new standard will be effective beginning <div style="display: inline; font-style: italic; font: inherit;"> January 1, 2021. </div>As of <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020, </div>the Company is continuing to evaluate the potential impact this ASU <div style="display: inline; font-style: italic; font: inherit;"> may </div>have on its financial position and results of operations upon adoption.</div></div>
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	993000
CY2019Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	991000
CY2019Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	994000
CY2019Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	993000
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-10000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-257000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-94000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1341000
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1417000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4727000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4687000
CY2020Q3	us-gaap	Gross Profit GrossProfit	1133000
CY2019Q3	us-gaap	Gross Profit GrossProfit	4382000
	us-gaap	Gross Profit GrossProfit	3609000
	us-gaap	Gross Profit GrossProfit	12959000
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1426000
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1340000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5086000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3658000
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-319000
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	663000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1770000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1586000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	236000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1958000
CY2020Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1833000
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-204000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-335000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	110000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	342000
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	560000
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	138000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1344000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	439000
	us-gaap	Interest Paid Net InterestPaidNet	60000
	us-gaap	Interest Paid Net InterestPaidNet	47000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5489000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1041000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	593000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1035000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1096000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1028000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	238000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	526000
CY2020Q3	us-gaap	Liabilities Liabilities	11038000
CY2019Q4	us-gaap	Liabilities Liabilities	10711000
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23980000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27531000
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3342000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5835000
CY2020Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	685000
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	678000
CY2020Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3617000
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1951000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	673000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3323000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-914000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2642000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5223000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3361000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-159000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-2050000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1107000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	627000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	768000
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	3000
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	30000
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	2542000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	677000
	us-gaap	Net Income Loss NetIncomeLoss	-3316000
	us-gaap	Net Income Loss NetIncomeLoss	2072000
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	3048000
	us-gaap	Operating Expenses OperatingExpenses	8566000
	us-gaap	Operating Expenses OperatingExpenses	9355000
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1409000
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1334000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4957000
	us-gaap	Operating Income Loss OperatingIncomeLoss	3604000
CY2020Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	288000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	853000
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4963000
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	884000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	963000
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4079000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2375000
	us-gaap	Operating Lease Payments OperatingLeasePayments	800000
	us-gaap	Operating Lease Payments OperatingLeasePayments	841000
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4508000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2875000
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.039
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y73D
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	885000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	943000
CY2020Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
CY2019Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-330000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-10000
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-297000
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-23000
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	14000
CY2020Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1000
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-48000
CY2019Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	82000
CY2019Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-331000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	47000
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	993000
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2978000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	33000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	880000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	896000
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	184000
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-35000
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17000
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-129000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	54000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-10000
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	225000
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1299000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1788000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2181000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	140000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	3810000
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9746000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10862000
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	305000
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	393000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	981000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1213000
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8063000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3754000
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5174000
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9852000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	16025000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	28963000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2346000
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10082000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4382000
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	896000
CY2019Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1238000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2858000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3455000
	us-gaap	Share Based Compensation ShareBasedCompensation	449000
	us-gaap	Share Based Compensation ShareBasedCompensation	509000
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	396000
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.49
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	3000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	584000
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	581000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.94
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.93
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.37
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y219D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y328D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y36D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	16820000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	15808000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	13924000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	12942000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	18747000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	18493000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	18477000
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	18020000
CY2020Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2020Q3	us-gaap	Treasury Stock Value TreasuryStockValue	10082000
CY2020Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2019Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	16000
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5526000
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5517000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5522000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5529000
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5526000
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5517000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5522000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5513000

Files In Submission

Name	View Source	Status
0001171843-20-007845-index-headers.html	Edgar Link	pending
0001171843-20-007845-index.html	Edgar Link	pending
0001171843-20-007845.txt	Edgar Link	pending
0001171843-20-007845-xbrl.zip	Edgar Link	pending
exh_311.htm	Edgar Link	pending
exh_312.htm	Edgar Link	pending
exh_321.htm	Edgar Link	pending
exh_322.htm	Edgar Link	pending
f10q_111020p.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pmd-20200930.xml	Edgar Link	completed
pmd-20200930.xsd	Edgar Link	pending
pmd-20200930_cal.xml	Edgar Link	unprocessable
pmd-20200930_def.xml	Edgar Link	unprocessable
pmd-20200930_lab.xml	Edgar Link	unprocessable
pmd-20200930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMDI
PSYCHEMEDICS CORP Stock $pmdi

2020 Q4 Form 10-Q Financial Statement

#000117184320007845 Filed on November 10, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI PSYCHEMEDICS CORP Stock $pmdi

2020 Q4 Form 10-Q Financial Statement

#000117184320007845 Filed on November 10, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI
PSYCHEMEDICS CORP Stock $pmdi